A gene expression signature for chemoradiosensitivity of colorectal cancer cells

International Journal of Radiation Oncology Biology Physics

Volumn 78, Issue 4, 2010, Pages 1184-1192

  Spitzner, Melanie ^a   Emons, Georg ^a   Kramer, Frank ^a   Gaedcke, Jochen ^a   Rave Fränk, Margret ^a   Scharf, Jens Gerd ^a   Burfeind, Peter ^a   Becker, Heinz ^a   Beissbarth, Tim ^a   Ghadimi, B Michael ^a   Ried, Thomas ^b   Grade, Marian ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

chemoradiotherapy; Colorectal cancer; gene expression profiling; resistance; response

Indexed keywords

CELL CULTURE; CELLS; DISEASES; PIGMENTS; POLYMERASE CHAIN REACTION; SIGNALING; TUMORS;

CHEMORADIOTHERAPY; COLORECTAL CANCER; GENE EXPRESSION PROFILING; RESISTANCE; RESPONSE;

GENE EXPRESSION;

CELL CYCLE PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUOROURACIL; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; STAT3 PROTEIN; WNT PROTEIN; ANTINEOPLASTIC ANTIMETABOLITE; DOK3 PROTEIN, HUMAN; RASSF1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; STAT3 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CANCER CELL; CELL SURVIVAL; COLORECTAL CANCER; DRUG SENSITIVITY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN DOK 3; PROTEIN TARGETING; RADIATION DOSE; RADIOSENSITIVITY; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; COLONIC NEOPLASMS; DRUG EFFECTS; DRUG RESISTANCE; GENE; GENETICS; MULTIMODALITY CANCER THERAPY; PROCEDURES; PROTO ONCOGENE; RADIATION RESPONSE; RECTAL NEOPLASMS; STATISTICAL MODEL; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIMETABOLITES, ANTINEOPLASTIC; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; DRUG RESISTANCE, NEOPLASM; FLUOROURACIL; GENE EXPRESSION PROFILING; GENES, CDC; GENES, ERBB-2; HUMANS; LINEAR MODELS; MITOGEN-ACTIVATED PROTEIN KINASES; RADIATION TOLERANCE; RECTAL NEOPLASMS; STAT3 TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEINS;

EID: 77958509184     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.06.023     Document Type: Article

References (43)

1. R.M. Neve, K. Chin, and J. Fridlyand A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes Cancer Cell 10 2006 515 527
2. D.A. Solomon, J.S. Kim, and H.W. Ressom Sample type bias in the analysis of cancer genomes Cancer Res 69 2009 5630 5633
3. U. Scherf, D.T. Ross, and M. Waltham A gene expression database for the molecular pharmacology of cancer Nat Genet 24 2000 236 244 (Pubitemid 30132190)
4. J.E. Staunton, D.K. Slonim, and H.A. Coller Chemosensitivity prediction by transcriptional profiling Proc Natl Acad Sci USA 98 2001 10787 10792
5. S.A. Eschrich, J. Pramana, and H. Zhang A gene expression model of intrinsic tumor radiosensitivity: Prediction of response and prognosis after chemoradiation Int J Radiat Oncol Biol Phys 75 2009 489 496
6. S. Eschrich, H. Zhang, and H. Zhao Systems biology modeling of the radiation sensitivity network: A biomarker discovery platform Int J Radiat Oncol Biol Phys 75 2009 497 505
7. J.M. Mariadason, D. Arango, and Q. Shi Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin Cancer Res 63 2003 8791 8812
8. R. Sauer, H. Becker, and W. Hohenberger Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
9. B.D. Minsky Is preoperative chemoradiotherapy still the treatment of choice for rectal cancer? J Clin Oncol 27 2009 5115 5116
10. J.G. Kuremsky, J.E. Tepper, and H.L. McLeod Biomarkers for response to neoadjuvant chemoradiation for rectal cancer Int J Radiat Oncol Biol Phys 74 2009 673 688
11. C.C. Uphoff, and H.G. Drexler Detection of mycoplasma contaminations in cell cultures by PCR analysis Hum Cell 12 1999 229 236
12. J.R. Masters, J.A. Thomson, and B. Daly-Burns Short tandem repeat profiling provides an international reference standard for human cell lines Proc Natl Acad Sci USA 98 2001 8012 8017
13. M. Rave-Frank, H. Schmidberger, and H. Christiansen Comparison of the combined action of oxaliplatin or cisplatin and radiation in cervical and lung cancer cells Int J Radiat Biol 83 2007 41 47
14. M. Grade, A.B. Hummon, and J. Camps A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets Int J Cancer Epub 2010 May 12
15. B.M. Bolstad, R.A. Irizarry, and M. Astrand A comparison of normalization methods for high density oligonucleotide array data based on variance and bias Bioinformatics 19 2003 185 193
16. G.K. Smyth Linear models and empirical Bayes methods for assessing differential expression in microarray experiments Stat Appl Genet Mol Biol 3 2004 Article3
17. Y. Benjamini, and Y. Hochberg Controlling the false discovery rate: A practical and powerful approach to multiple testing J R Stat Soc, Series B (Methodol) 57 1995 289 300
18. G.K. Smyth Limma: Linear Models for Microarray Data 2005 Springer New York
19. C. Ramakers, J.M. Ruijter, and R.H. Deprez Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data Neurosci Lett 339 2003 62 66
20. M. Grade, B.M. Ghadimi, and S. Varma Aneuploidy-dependent massive deregulation of the cellular transcriptome and apparent divergence of the Wnt/beta-catenin signaling pathway in human rectal carcinomas Cancer Res 66 2006 267 282
21. M. Grade, P. Hormann, and S. Becker Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas Cancer Res 67 2007 41 56
22. M. Honma, O. Higuchi, and M. Shirakata Dok-3 sequesters Grb2 and inhibits the Ras-Erk pathway downstream of protein-tyrosine kinases Genes Cells 11 2006 143 151
23. N.P. Zauber, S.P. Marotta, and E. Berman Molecular genetic changes associated with colorectal carcinogenesis are not prognostic for tumor regression following preoperative chemoradiation of rectal carcinoma Int J Radiat Oncol Biol Phys 74 2009 472 476
24. J. Gaedcke, M. Grade, and K. Jung KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy Radiother Oncol 94 2010 76 81
25. I.A. Kim, S.S. Bae, and A. Fernandes Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines Cancer Res 65 2005 7902 7910
26. J.S. Oh, J.J. Kim, and J.Y. Byun Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras Int J Radiat Oncol Biol Phys 76 2010 5 8
27. P. Dent, A. Yacoub, and P.B. Fisher MAPK pathways in radiation responses Oncogene 22 2003 5885 5896
28. G. Hamilton, K.S. Yee, and S. Scrace ATM regulates a RASSF1A-dependent DNA damage response Curr Biol 19 2009 2020 2025
29. B.B. Aggarwal, A.B. Kunnumakkara, and K.B. Harikumar Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann NY Acad Sci 1171 2009 59 76
30. A. Vigneron, E. Gamelin, and O. Coqueret The EGFR-STAT3 oncogenic pathway up-regulates the Eme1 endonuclease to reduce DNA damage after topoisomerase I inhibition Cancer Res 68 2008 815 825
31. J.A. Bonner, H.Q. Trummell, and C.D. Willey Inhibition of STAT-3 results in radiosensitization of human squamous cell carcinoma Radiother Oncol 92 2009 339 344
32. M. Akamatsu, T. Matsumoto, and K. Oka c-erbB-2 oncoprotein expression related to chemoradioresistance in esophageal squamous cell carcinoma Int J Radiat Oncol Biol Phys 57 2003 1323 1327
33. P. Bevan Insulin signaling J Cell Sci 114 2001 1429 1430
34. K. Yavari, M. Taghikhani, and M.G. Maragheh SiRNA-mediated IGF-1R inhibition sensitizes human colon cancer SW480 cells to radiation Acta Oncol 49 2010 70 75
35. R.J. van Alphen, E.A. Wiemer, and H. Burger The spliceosome as target for anticancer treatment Br J Cancer 100 2009 228 232
36. R.T. Moon, A.D. Kohn, and G.V. De Ferrari WNT and beta-catenin signaling: Diseases and therapies Nat Rev Genet 5 2004 691 701
37. W.A. Woodward, M.S. Chen, and F. Behbod WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells Proc Natl Acad Sci USA 104 2007 618 623
38. B.M. Ghadimi, M. Grade, and M.J. Difilippantonio Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy J Clin Oncol 23 2005 1826 1838
39. S.A. Amundson, K.T. Do, and L.C. Vinikoor Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen Cancer Res 68 2008 415 424
40. A. Walther, E. Johnstone, and C. Swanton Genetic prognostic and predictive markers in colorectal cancer Nat Rev Cancer 9 2009 489 499
41. C. Rodel, J. Haas, and A. Groth Spontaneous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: Survivin as a radioresistance factor Int J Radiat Oncol Biol Phys 55 2003 1341 1347
42. F. Rodel, J. Hoffmann, and L. Distel Survivin as a radioresistance factor; and prognostic and therapeutic target for radiotherapy in rectal cancer Cancer Res 65 2005 4881 4887
43. F. Rodel, B. Frey, and W. Leitmann Survivin antisense oligonucleotides effectively radiosensitize colorectal cancer cells in both tissue culture and murine xenograft models Int J Radiat Oncol Biol Phys 71 2008 247 255